|
|||||
|
|
Rivaroxaban in patients undergoing surgical mitral valve repair |
|
| Authors: | Noohi Feridoun Sadeghipour Parham Kordrostami Sirous Shafe Omid Maleki Majid Kyavar Majid Bakhshandeh Hooman Rezaei Yousef Rokni Mehrad Moosavi Jamal Amin Ahmad Tashakori Beheshti Ahmad Hosseini Saeid |
| Affiliation: | 1.Heart Valve Diseases Research Center, Rajaie Cardiovascular, Medical, and Research Center, Iran University of Medical Sciences, Vali-Asr Ave, 1995614331, Tehran, Iran ;2.Cardiovascular Intervention Research Center, Rajaie Cardiovascular, Medical, and Research Center, Iran University of Medical Sciences, Tehran, Iran ;3.Clinical Trial Center, Rajaie Cardiovascular, Medical, and Research Center, Iran University of Medical Sciences, Tehran, Iran ;4.Rajaie Cardiovascular, Medical, and Research Center, Iran University of Medical Sciences, Tehran, Iran ; |
| Abstract: | Journal of Thrombosis and Thrombolysis - In patients undergoing mitral valve repair (MVre), a 3-month course of anticoagulation is currently recommended. The role of the non-vitamin K antagonist... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |